Injection drug use (IDU), fueled by the US opioid crisis has resulted in a dramatic increase in HCV and HIV infections. People with OUD have 28 times increased risk of HIV infection. Approximately 1 in 10 new HIV infections is attributed to IDU. The Centers for Disease Control and Prevention (CDC) reported that there was a 68% increase in infants born to HCV-infected mothers from 2011-2014. Furthermore, there was a 233% increase in new HCV infections between 2010-2016. These data, together with the Indiana HIV outbreak in which > 90% were coinfected with HCV, underscore the need for integrated HIV and HCV testing, treatment, and prevention among OUD populations, especially those in the rural, VA, and correctional settings.

The CME Outfitters, LLC Infectious Disease Hub is designed to provide clinicians with the resources and guidelines for screening, testing, and treatment of HIV and HCV. In addition, the Infectious Disease Hub also includes resources for patients on HIV and HCV care.

Primary Immunodeficiency Disorders

Shared Decision Making

Dr. Mark Ballow talks about strategies for patients and their caregivers to improve communication with their doctors and healthcare teams.
Primary Immunodeficiency Resources

A guide on PIDs for patients and caregivers from the Immune Deficiency Foundation

Health-Related Quality of Life in Patients With CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter Study

Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee

A Grassroots Approach to Weed Out HIV and HCV in Special OUD Populations

Participate NowIn this CME Outfitters Live and On Demand, expert faculty discuss strategies for HIV and HCV testing in special OUD populations, applying evidence-based treatment approaches, as well as prevention strategies, including PrEP, for patients with OUD at high risk for HIV infection.

Overcoming Challenges in HIV and HCV Testing and Linkage to Care

Participate NowThe first part of this CME Outfitters BriefCase, a case-based faculty interview, examines a real-world case highlighting strategies for testing at-risk patients for HIV and HCV, including OUD populations. Further, faculty discuss how to interpret lab results and the appropriate steps to take for this patient population.

Comprehensive Approaches for HIV Prevention in High-Risk Patients with OUD

Participate NowThe second part of this CME Outfitters BriefCase, a case-based faculty interview, aims to educate clinicians on PrEP for HIV prevention, including what patients are - or are not - candidates for PrEP, as well as the necessary steps to take before initiating PrEP.

Management of a Patient with HIV-HCV Coinfection and Substance Use Disorder

Participate NowThe final installment of this three-part CME Outfitters BriefCase, a case-based faculty interview, features expert faculty discussing implementation of team-based approaches for the management of patients with HIV-HCV coinfection and substance use disorder in order to improve care for these patients.

A Grassroots Approach to Weed Out HIV and HCV in Special OUD Populations

Participate NowIn this CMEO Podcast, expert faculty discuss strategies for HIV and HCV testing in special OUD populations, applying evidence-based treatment approaches, as well as prevention strategies, including PrEP, for patients with OUD at high risk for HIV infection.